Abingdon, United Kingdom

Konstantinos Rampalako

This inventor holds 1 USPTO granted patent. Top assignee: Ucbbiopharma Srl. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Konstantinos Rampalako. Retrieved from https://idiyas.com/inventor/konstantinos-rampalako

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Konstantinos Rampalako: Innovator in Pharmaceutical Applications

Introduction

Konstantinos Rampalako is an inventor based in Abingdon, Oxfordshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent application. His work focuses on developing new compounds that can address various medical conditions.

Latest Patent Applications

One of his notable patent applications is titled "DIHYDRO-CYCLOPENTA-ISOQUINOLINE SULFONAMIDES DERIVATIVES." This invention relates to dihydro-cyclopenta-isoquinoline derivatives of a specific formula. The application details processes for preparing these compounds, pharmaceutical compositions containing them, and their potential use in treating disorders caused by IgE. These disorders include allergic responses, non-allergic mast cell responses, and certain autoimmune responses, particularly those caused by the interaction of IgE with the FcεRI receptor.

Conclusion

Konstantinos Rampalako's innovative work in pharmaceutical applications highlights his commitment to addressing significant health challenges through scientific research. His contributions, although currently limited to patent applications, show promise for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…